Centene Corporation (CNC) recently delivered strong first-quarter results exceeding market expectations, with revenue reaching $46.6 billion and adjusted diluted earnings per share hitting $2.90. However, the company’s increased medical loss ratio forecast has raised concerns about rising Medicaid expenses impacting future profitability, leading to a 7.3% decline in its stock price. Despite this, Centene remains optimistic, with higher 2025 revenue guidance attributed to improved individual marketplace plans and stronger Medicare member retention. This positive outlook contrasts with the challenging earnings season observed across the managed-care industry, where rivals like UnitedHealth Group (UNH) and Molina Healthcare (MOH) are also facing headwinds.